Adaptive Biotechnologies Corporation
USD15.14
-0.09 (-0.59%)
CEO
Chad Robins
IPO Date
2019-06-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.18
Prev. Close
$15.23
Day Low
$14.84
Day High
$15.33
52W Low
$9.78
52W High
$20.76
Market Cap
$2.42B
Volume
1.59M
| 14,707 |
| $8.46 |
| 29 Apr 2026 | RUBINSTEIN JULIE | President and COO | S-Sale | Disposed | 19,037 | $14.23 |
| 29 Apr 2026 | RUBINSTEIN JULIE | President and COO | M-Exempt | Disposed | 14,707 | $8.46 |
| 24 Apr 2026 | RUBINSTEIN JULIE | President and COO | M-Exempt | Acquired | 14,722 | $8.46 |
| 24 Apr 2026 | RUBINSTEIN JULIE | President and COO | S-Sale | Disposed | 19,060 | $14.13 |
| 24 Apr 2026 | RUBINSTEIN JULIE | President and COO | M-Exempt | Acquired | 14,722 | $8.46 |
| 24 Apr 2026 | RUBINSTEIN JULIE | President and COO | S-Sale | Disposed | 19,060 | $13.74 |
| 24 Apr 2026 | RUBINSTEIN JULIE | President and COO | M-Exempt | Acquired | 14,722 | $8.46 |
| 24 Apr 2026 | RUBINSTEIN JULIE | President and COO | S-Sale | Disposed | 19,060 | $14.02 |